Pacer Advisors Inc. Purchases 47,729 Shares of Healthpeak Properties, Inc. $DOC

Pacer Advisors Inc. raised its position in Healthpeak Properties, Inc. (NYSE:DOC) by 87.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 102,445 shares of the real estate investment trust’s stock after buying an additional 47,729 shares during the quarter. Pacer Advisors Inc.’s holdings in Healthpeak Properties were worth $1,683,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in DOC. Advocate Investing Services LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $26,000. WPG Advisers LLC raised its position in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in Healthpeak Properties during the second quarter worth $33,000. Clearstead Advisors LLC boosted its holdings in shares of Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares in the last quarter. Finally, Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties in the 4th quarter valued at $31,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.23% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on DOC. Weiss Ratings reissued a “hold (c)” rating on shares of Healthpeak Properties in a report on Wednesday. BMO Capital Markets raised their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Raymond James Financial initiated coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Evercore downgraded shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target for the company. in a research note on Monday, May 11th. Finally, Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 27th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $20.97.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $21.37 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 2.96 and a current ratio of 3.02. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The company has a 50 day simple moving average of $21.20 and a two-hundred day simple moving average of $18.80. The company has a market capitalization of $14.73 billion, a PE ratio of 61.07, a P/E/G ratio of 3.31 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same period in the prior year, the firm posted $0.46 EPS. The company’s quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.76 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.7%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.